Funding · The Decoder ·
Alphabet's Isomorphic Labs raises $2.1 billion to scale AI drug discovery toward clinical trials
Isomorphic Labs, led by DeepMind co-founder Demis Hassabis, raised $2.1 billion in a Series B round led by Thrive Capital. The company plans to use the funds to expand its IsoDDE platform and advance drug candidates toward clinical trials.